16.1 Evaluating Dialysis Technology and Supplies

Define the Need Before Comparing Products

A unit may evaluate a machine, dialyzer, bloodline, needle, disinfectant or monitoring device because patient needs or current performance have changed. Begin by defining the problem. Low adequacy might reflect lost treatment time or access recirculation rather than a deficient dialyzer. Repeated alarm difficulties might arise from configuration or training. Buying a product without identifying the cause can add cost and risk while leaving the problem unresolved.

Consider the patient population: adults or children, acute or maintenance therapy, home treatment, access flows, sensitivity to extracorporeal volume, mobility and infection risk. A device well suited to one population may be inappropriate for another. Include clinical nurses, the medical director, technical staff, infection prevention and procurement in evaluation. Frontline experience can identify handling problems that a specification sheet misses.

Dialyzer and Disposable Evaluation

Compare labeled clearance at the relevant blood and dialysate flows, membrane properties, surface area, priming volume, water permeability, middle-solute performance and albumin retention. In-vitro clearance does not establish the patient's delivered Kt/V. A larger surface or higher hydraulic coefficient may not solve a limited-access-flow problem. High efficiency and high flux describe different performance characteristics.

Verify sterilization method, hypersensitivity warnings, approved reuse status if relevant, packaging and compatibility. Check the specific membrane's ACE-inhibitor warning rather than assuming all modified products share the same labeling. Evaluate bloodline connector security, pressure-monitor protection, chamber visibility, air-detector compatibility and residual volume. Needle products have labeled gauge/flow and handling limits; mechanical fit alone is not approval.

Delivery Systems and Safety Features

A dialysis machine proportions fluid, controls prescribed removal, monitors parameters and responds to unsafe conditions. Evaluate its mixing system, conductivity and temperature monitoring, volumetric balance, pressure alarms, air detector, venous clamp and blood-leak detector. Know what each alarm can and cannot detect. A venous-pressure alarm may not detect every needle dislodgement, and conductivity cannot independently confirm potassium identity.

Central, individual proportioning, single-pass and specialized prepared-fluid systems have different operational considerations. Single-pass systems send used dialysate to drain rather than recirculating it as fresh fluid. Confirm water demand, drain/backflow arrangements, electrical requirements and allowed concentrates. Evaluate peak simultaneous demand, not only performance of a single idle machine.

AAMI and Validated Systems

AAMI and ISO standards address fluid quality and related systems, while US CMS regulations incorporate specified older standards. The unit needs a documented understanding of both applicable minimums and any stricter adopted targets. A marketing claim of 'AAMI compliant' is not sufficient without the specific standard, edition, test and operating conditions. Water, standard dialysis fluid and ultrapure fluid are distinct categories.

Technical evaluation includes commissioning, water analysis, baseline performance, disinfection validation and residual clearance where applicable. Each process must use compatible materials and approved concentrations or temperatures. A heat-disinfection claim does not establish that every component in an existing loop is heat-rated. Involve qualified technical staff and follow the installation and validation process before exposing patients.

Trial, Training and Change Control

A controlled product evaluation identifies participants, outcome measures, adverse-event reporting and stopping criteria. Confirm authorization and any applicable consent or research oversight. Staff learn the new setup, alarm meanings, priming, termination and disinfection before routine use. A brief demonstration without return demonstration may miss a critical handling difference.

Update the approved procedure and supply identification so old and new components are not mixed unintentionally. Labels, stock location and electronic order names should prevent confusion. A concentrate change with a similar package can create a hazardous mismatch even when conductivity appears acceptable. Verify the first treatments carefully and collect staff feedback.

Cost and Quality

Consider total cost: consumables, maintenance, training, water/electricity, service, waste and consequences of failure. A lower purchase price is not automatically lower total cost. Equally, a more expensive product is not automatically clinically superior. Compare meaningful outcomes and operational reliability, avoid vendor-only evidence and document the rationale.

Monitor after adoption. Track alarms, treatment interruptions, reactions, delivered adequacy and user errors using consistent definitions. Investigate a cluster rather than dismissing it as unfamiliarity. Preserve implicated supplies, lot numbers and settings after serious events, and follow recall or device-reporting processes when indicated.

Scenario

A vendor proposes a higher-clearance dialyzer to correct falling Kt/V. The unit first finds that frequent early termination and low achieved blood flow account for the decline. Correcting those problems may be more useful than changing membrane surface. If a new dialyzer is still considered, evaluate its actual performance at achievable flows, priming volume, compatibility and warnings. Good evaluation joins engineering evidence with the patient's real treatment conditions.

Sources: CMS technical requirements, FDA medical devices.